Study outcome won't sway company on eye drug
Wednesday, August 27, 2008 - 13:35
in Health & Medicine
WASHINGTON (AP) -- What does a company do when there's anecdotal evidence that two of its drugs are equally effective in treating a leading cause of blindness in the elderly, one costing patients $60 per treatment and the other $2,000?...